Aim: Acute pancreatitis in patients with severe motor and intellectual disabilities (SMID) is a rare but life-threatening condition. Possible causes of acute pancreatitis in these patients including valproic acid therapy, hypothermia and nasoduodenal tube feeding, have not yet been investigated in detail. This study aimed to investigate the risk factors for acute pancreatitis in patients with SMID. Methods: We reviewed 5 SMID patients with acute pancreatitis and 15 SMID patients without acute pancreatitis.
Introduction
Acute pancreatitis in patients with severe motor and intellectual disabilities (SMID) may be life-threatening. Moreover, it can be difficult to diagnose because signs and symptoms are usually nonspecific: fever, abdominal distention, gastric bleeding, bilious vomiting, and diarrhea. A delay in diagnosis and treatment can have very serious, even fatal. Various risk factors for acute pancreatitis occurring in patients with SMID have been reported: valproic acid (VPA) therapy, 1 scoliosis, nasoduodenal tube feeding, and hypothermia. 2 However the mechanisms by which these factors work have not been examined in details. This study examined the risk factors of acute pancreatitis in patients with SMID to aid in the prevention of this critical condition.
Patients and methods
SMID patients with acute pancreatitis (n = 5: 2 males, 3 females) and without acute pancreatitis (n = 15: 8 males, 7 females) were identified retrospectively from a database containing information about all children who visited our division from 2007 to 2012. All patients were bed-ridden and diagnosed with SMID patinets. Table 1 displays the clinical profiles of patients with SMID in acute pancreatitis group (pancreatitis group). Underlying diseases in SMID patients without pancreatitis (control group) included hypoxic-ischemic encephalopathy (n = 2), severe neonatal asphyxia (n = 4), microcephaly and brain anomaly (n = 2), bacterial meningoencephalitis (n = 1), sepsis associated encephalopathy (n = 1), cerebral palsy (n = 1), Sotos syndrome (n = 1), congenital central hypoventilation syndrome (n = 1), Niemann-Pick disease type C (n = 1), and adrenoleukodystrophy (n = 1). In the pancreatitis group, acute pancreatitis recurred four times in one patient and eight times in another patient; in these two patients abdominal echo and magnetic resonance cholangiopancreatography were performed. No anomalous arrangement of pancreaticobiliary ducts or biliary duct dilatation were recognized. Antibody levels to cytomegalovirus, varicella-zoster virus, coxsackie virus, Epstein-Barr virus, and hepatitis A, B, and C virus, were examined in one of these patients, but no elevated levels were detected.
In two patients with SMID in pancreatitis group, the serum VPA levels at the onset of acute pancreatitis was 116.4μg/ml and 63.1μg/ml, the duration of VPA treatment was 7 years and 10 months, 2 years and 6 months, respectively. In two SMID patients medicated by VPA in control group, the serum concentration of VPA was 75.6μg/ml and 23.5μg/ml, the duration of VPA treatment was 3 years and 6 months, 4 years and 3months, respectively.
Diagnosis of acute pancreatitis was made on the basis of laboratory findings (elevation of serum pancreatic amylase and lipase) and abdominal computed tomography (CT) findings (pancreatic enlargement and infiltration of surrounding fat).
No gallstone revealed on abdominal CT in any patient.
Patients were compared in terms of following parameters: age; sex; respiratory care; feeding methods; valproic acid therapy; serum levels of total cholesterol, triglyceride, total protein and albumin; height; body weight; body surface area (BSA); body mass index [BMI, calculated by using the following equation:
daily calorie intake; daily calorie intake per unit of BSA; daily calorie intake per kilogram of body weight. In the pancreatitis group, the serum levels of total cholesterol, triglyceride were selected at the onset of acute pancreatitis and the serum levels of total protein, albumin were selected that had been collected when patients were in good general condition one or two months before the onset of acute pancreatitis. For the two patients with recurrent disease in the pancreatitis group, quantitative data were selected that had been collected before the first episode of acute pancreatitis.
Statistical analysis
Quantitative data were retrospectively examined using the Mann-Whitney U test.
The chi-square test was applied for comparison of results by sex, respiratory care, feeding methods, VPA therapy. Quantitative and qualitative data except for VPA therapy was analyzed after excluding the SMID patients medicated by VPA. The significance level was determined as P < 0.05.
Results
Significant difference in serum albumin level was observed (P < 0.05) between patients in the pancreatitis and control groups. No significant difference in age, sex, respiratory care, feeding method, VPA therapy, height, body weight, BSA, BMI, daily calorie intake, daily calorie intake per unit of BSA, daily calorie intake per kilogram of body weight, serum total protein, total cholesterol and triglyceride level were evident between groups (Tables 2 and 3 ).
Discussion
Acute pancreatitis is triggered by pancreatic autodigestion, which is followed by activation of pancreatic enzymes. Some etiologies of acute pancreatitis were known, including viral infection, multisystem disease, hyperlipidemia, drugs, trauma, autoimmune disease, congenital anomalies of the pancreaticobiliary system, malnutrition. 3 VPA is known as one of the drug caused with acute pancreatitis. In this study, the risk of VPA therapy was untried because the numbers medicated by VPA were poor. The past articles show that dose, duration of treatment, serum VPA levels are no concern of acute pancreatitis. 1, 4 Additionally there is no evidence that VPA is an independent risk factor of acute pancreatitis. 5 Recurrent acute pancreatitis in anorexia and bulimia 6 and acute and chronic pancreatitis in patients with protein energy malnutrition were previously reported. 7 Cleghorn et al. reported that acinar cell damage and ductal obstruction were reflected by higher levels of serum trypsinogen in moderately and severely malnourished patients than in normally nourished patients. 8 Moreover, marked acinar cell atrophy has been demonstrated in malnourished animals, 9 and increased zymogen granule release has been found in malnourished patients. 10 A protein-deficient diet causes a decrease in size and number of zymogen granules in acinar cells because zymogen granules are produced from protein; this results in acinar cell destruction. 11, 12 In addition, protein energy malnutrition (marasmus, kwashiorkor) may lead to oxidative damage to the pancreas in a system with poor antioxidant reserves and inflammatory damage to the pancreas by elevation of the cytokines interleukin-1, interleukin-6, and tumor necrosis factor-α.
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In this study, serum albumin levels in SMID patients with acute pancreatitis were significantly lower than those in SMID patients without acute pancreatitis. No protein extravasation or urinary protein excretion were evident, probably because these laboratory data were collected at a time when the patients were in good general condition. The results of urine protein tests in the patients included in this study were negative (data not shown). Thus, in this study data for serum albumin levels were considered as a reflection of patients' nutritional status. However, a more detailed evaluation of nutritional status is required, including examination of rapid turnover protein; prealbumin, transferrin, and retinol binding protein for conclusive information on nutritional status in patients with SMID.
Protein breakdown in malnourished patients reduces the body's supply of amino acids and results in decreased synthesis of plasma proteins. 13 Moreover, in patients on long-term bed rest, muscle wasting is caused by protein breakdown as well. In addition, recurrent infection increases the body's protein consumption. This inadequate protein turnover may result in hypoalbuminemia in patients with SMID who are malnourished, bed-ridden, and subject to recurrent infection.
Causes of acute pancreatitis in patients with SMID may be related to pathological changes in the pancreas occurring as a result of malnutrition similar to those observed in patients with anorexia nervosa and protein energy malnutrition. Fortunately, pancreatic malfunction due to malnutrition is reversible. 11 Adequate nutritional control and minimizing the opportunity of infections may improve pancreatic function and prevent development of acute pancreatitis.
In conclusion, the results of this study indicate that hypoalbuminemia are risk factors for acute pancreatitis in patients with SMID. Adequate management of nutritional status in patients with SMID is important to prevent development of pancreatitis.
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